Genomic Prediction

Hsu, a physicist with a Ph.D. from UC Berkeley and a history of successful tech startups, became interested in computational genomics and the application of machine learning to DNA analysis. His entrepreneurial background includes founding SafeWeb, an anonymizer service acquired by Symantec. Treff, the company's Chief Scientific Officer, has a personal connection to the mission; diagnosed with Type 1 Diabetes as a graduate student, his life's work has been dedicated to advancing preimplantation genetic testing. He holds a Ph.D. in Biochemistry, has published over 120 papers in Reproductive Genetics, and previously directed molecular biology research at Reproductive Medicine Associates of New Jersey.

The company's business is centered around its proprietary LifeView™ PGT platform, which serves IVF clinics and prospective parents. Revenue is generated by providing a suite of genetic tests that analyze embryos prior to implantation. This model helps clients increase the likelihood of a successful pregnancy while reducing the risk of genetic diseases. The firm's primary clients are fertility clinics that integrate Genomic Prediction's tests into their IVF offerings, and directly to patients seeking to make informed decisions about embryo selection.

Genomic Prediction's core service is Preimplantation Genetic Testing (PGT), which includes several specific tests. The LifeView Embryo Health Score (EHS) evaluates embryos for polygenic conditions, which are influenced by multiple genes, such as heart disease, certain cancers, and diabetes. This differs from traditional testing by providing a risk score rather than a simple diagnostic, allowing for a comparative ranking of embryos. The platform also offers PGT-A for aneuploidy (abnormal chromosome numbers), PGT-SR for chromosomal rearrangements, and PGT-M for single-gene disorders. By applying machine learning and AI to large genomic datasets, the company can identify genetic markers linked to various conditions, offering a more detailed analysis than previously possible. Keywords: preimplantation genetic testing, PGT, IVF genetic testing, embryo screening, polygenic risk score, LifeView, reproductive genetics, embryo health score, aneuploidy screening, PGT-A, PGT-P, single-gene disorders, computational genomics, IVF health outcomes, embryo selection, genetic risk reduction, fertility treatments, chromosome abnormalities, genetic diagnostics, Stephen Hsu, Nathan Treff